Selected article for: "community spread and International license"

Author: Michael P McRae; Glennon W Simmons; Nicolaos J Christodoulides; Zhibing Lu; Stella K Kang; David Fenyo; Timothy Alcorn; Isaac P Dapkins; Iman Sharif; Deniz Vurmaz; Sayli S Modak; Kritika Srinivasan; Shruti Warhadpande; Ravi Shrivastav; John T McDevitt
Title: Clinical Decision Support Tool and Rapid Point-of-Care Platform for Determining Disease Severity in Patients with COVID-19
  • Document date: 2020_4_22
  • ID: h4lsvgxo_58
    Snippet: Future work may also involve developing a test on the same platform for population-based COVID-19 community surveillance in clinical settings (ambulances, hospitals, clinics, laboratories) and for public settings that are at risk for community spread (businesses, schools, airports, train stations). The development and distribution of a portable, affordable, widely distributed smart sensor technology with anticipated availability/readiness within .....
    Document: Future work may also involve developing a test on the same platform for population-based COVID-19 community surveillance in clinical settings (ambulances, hospitals, clinics, laboratories) and for public settings that are at risk for community spread (businesses, schools, airports, train stations). The development and distribution of a portable, affordable, widely distributed smart sensor technology with anticipated availability/readiness within months promises to be an important solution for the management of the current coronavirus crisis as well as an adaptable tool to combat future threats of a new virus or biological threat. Likewise, in addition to this COVID-19 Severity Score, a sustaining contribution of this work may be in the . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and clinical setting: 1, 2
    • cc NC ND International license and community spread: 1, 2, 3, 4, 5, 6
    • cc NC ND International license and community spread risk: 1
    • cc NC ND International license and community surveillance: 1, 2
    • cc NC ND International license and future work: 1, 2, 3, 4, 5
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical setting and community spread: 1, 2, 3, 4, 5
    • clinical setting and community surveillance: 1, 2
    • clinical setting and coronavirus crisis: 1
    • clinical setting and distribution development: 1
    • clinical setting and future work: 1, 2, 3, 4, 5, 6
    • clinical setting and International license: 1, 2
    • community spread and coronavirus crisis: 1
    • community spread and distribution development: 1
    • community spread and future work: 1, 2, 3
    • community spread and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • community spread risk and International license: 1
    • community surveillance and International license: 1, 2, 3
    • coronavirus crisis and International license: 1